Circulating ICAM-1 levels in falciparum malaria are high but unrelated to disease severity

Trans R Soc Trop Med Hyg. 1996 May-Jun;90(3):274-6. doi: 10.1016/s0035-9203(96)90244-8.

Abstract

Intercellular adhesion molecule 1 (ICAM-1) mediates the binding of Plasmodium falciparum to vascular endothelium. In a case-control study of falciparum malaria in Gambian children, we have looked for evidence that a generalized increase in expression of ICAM-1 is associated with cerebral malaria. Plasma levels of circulating ICAM-1 (cICAM-1) were significantly higher in 246 children with acute malaria than in 156 children with non-malarial illnesses. cICAM-1 levels correlated with levels of tumour necrosis factor (TNF), interleukin 1 alpha (IL-1 alpha) and interferon gamma, supporting the view that these cytokines are responsible for a general upregulation of ICAM-1 expression in malaria. However, while it has been previously shown that TNF and IL-1 alpha levels were related to disease severity, this was not the case for cICAM-1. It may be that differences in the distribution of ICAM-1, rather than its total level of expression, are critical in determining the clinical outcome in malaria.

MeSH terms

  • Case-Control Studies
  • Child
  • Child, Preschool
  • Coma / blood
  • Coma / complications
  • Humans
  • Infant
  • Intercellular Adhesion Molecule-1 / blood*
  • Interferon-gamma / blood
  • Interleukin-1 / blood
  • Malaria, Cerebral / blood*
  • Malaria, Cerebral / complications
  • Regression Analysis
  • Severity of Illness Index
  • Tumor Necrosis Factor-alpha / analysis

Substances

  • Interleukin-1
  • Tumor Necrosis Factor-alpha
  • Intercellular Adhesion Molecule-1
  • Interferon-gamma